Back to Agenda
Session 4: Part 2
Session Chair(s)
Hakan Aribas, MD
CEO and Founder, ORION Healthcare, Turkey
Session 4: Machines Era in MI
Learning Objective : At the conclusion of this session, participants should: • Understand the market headwinds and how they can impact the Material Review Function • Understand the importance of medical-contextualized modern technologies • Learn how modern technologies can transform the Material Review Function and enable it to better meet business needs
Speaker(s)
Natural language processing in medical information and communication
Vilius Fokas
CEO & Co-Founder, Nexentria Inc., United States
Innovative MI Solution to Engage with Customers During and Beyond the Pandemic
Jennifer Liang, MS, MSc
Medical Information Technology & Analytics Lead, Global Medical Information, Bayer Inc., Canada
Transforming the Material Review Function through modern technologies
Sudy Vengarai
Sales Manager, Indegene, United States
Have an account?